Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 4

2(33.3%)

Phase 3

2(33.3%)

6Total

N/A(2)

Phase 4(2)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT03153527Phase 4Recruiting

Taper Or Abrupt Steroid Stop: TOASSTtrial

Role: collaborator

NCT07145580Recruiting

Combined Lactulose H2-breath Test With Abdominal Imaging

Role: collaborator

NCT02386735Not ApplicableTerminated

Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD

Role: collaborator

NCT05053048Not ApplicableCompleted

Effect of an Alumina Free Device Surface on BMD in Patients Implanted With an SL-PLUS™ Femoral Stem for THA

Role: lead

NCT02358447Completed

SPECT-CT for Assessment of Total Knee Arthroplasty in Navigated and Non-navigated Total Knee Arthroplasty

Role: lead

NCT02867501Completed

Venous Distension in Patients With Aneurysmatic Arterial Disease

Role: lead

NCT00804063Completed

Serum Citrate in Diagnosis and Follow-up for Glaucoma

Role: collaborator

NCT02097888Unknown

Influence of Erythropoietin on Bone Marrow Microenvironment

Role: lead

NCT01585051Phase 3Completed

Effect of Vitamin D Supplementation on Blood Pressure and HbA1c Levels in Patients With T2D

Role: lead

NCT00509405Phase 3Completed

Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

Role: lead

NCT00712205Phase 4Unknown

Vitamin D for the Treatment of Severe Asthma

Role: lead

NCT00863967Unknown

Early Detection of Arteriosclerosis

Role: lead

All 12 trials loaded